|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Minerva Biotechnologies Corp.
| | | Phone: | (781) 487-0200 x103 | Fax: | (781) 478-0227 | Year Established: | 1999 | Ticker: | NASDAQ | Exchange: | NERV | Main Contact: | Cynthia Bamdad, Ph.D., Founder & CEO | | Other Contacts: | Ron Axelrod, VP, Operations
| |
| Company Description | Minerva Biotechnologies is a pioneer in the field of stem cells and cancer stem cells. Minerva was first to discover that cancer cells hijack an otherwise normal stem cell growth mechanism, involving a growth factor receptor called MUC1* (pronounced muk 1 star). The Company is developing a panel of anti-cancer drugs that target a cancer-specific MUC1* growth factor receptor and a testis specific cancer antigen that promotes metastasis. | |
|
|
|
|
|